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Abstract

Placenta-derived amniotic epithelial cells (AECs), a great cell source for tissue engineering and stem cell
therapy, are immunologically inert in their native state; however, immunological changes in these cells
after culture and differentiation have challenged their applications. The aim of this study was to
investigate the effect of 2D and 3D scaffolds on human lymphocyte antigens (HLA) expression by AECs.
The effect of different preparation parameters including pre-freezing time and temperature was
evaluated on 3D chitosan–gelatine scaffolds properties. Evaluation of MHC class I, HLA-DR and HLA-G
expression in AECs after 7 d culture on 2D bed and 3D scaffold of chitosan–gelatine showed that
culture of AECs on the 2D substrate up-regulated MHC class I and HLA-DR protein markers on AECs
surface and down-regulated HLA-G protein. In contrast, 3D scaffold did not increase protein expression
of MHC class I and HLA-DR. Moreover, HLA-G protein expression remained unchanged in 3D culture.
These results confirm that 3D scaffold can remain AECs in their native immunological state and
modification of physical properties of the scaffold is a key regulator of immunological markers at the
gene and protein expression levels; a strategy which circumvents rejection challenge of amniotic stem
cells to be translated into the clinic.
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Introduction

Cell therapy and regenerative medicine are the modern approaches to restoration and maintenance of
tissue function. These fields of study are partially based on using stem cells to generate biological
substitutes [1]. The amniotic membrane (AM), which is the innermost layer of foetal membranes, is an
enriched source of stem cells. AM is consist of five layers including an epithelium, a basement
membrane, a compact layer, a fibroblast layer and a spongy layer [2]. AM’s potential in healing skin
wounds and burn [3], reconstruction of cornea [4], engineering vascular tissues [5] and antibacterial
activities [1] have made it as a suitable biomaterial for being used in clinical applications. Amniotic
epithelial cells (AECs) have a great potential for use in cell therapy and tissue engineering. These cells
are directly in contact with amniotic fluid during the pregnancy and display anti-cancer properties [6].
This characteristic is due to the induction of apoptosis and cell cycle arrest in cancer cells alongside the
inhibition of angiogenesis. It has been hypothesized that the inhibition of heat shock protein 90
(HSP90) is responsible for anti-cancer properties of AECs [7]. Also, it has been shown that cell cycle is
arrested in G1/S phase in cancer cells after treatment with AECs’ condition medium. Furthermore, the
expression of angio-modulatory factors, such as thrombospondin-1, endostatin and heparan sulphate
and all tissue inhibitors of metalloproteinase (TIMP-1, 2, 3 and 4) result in inhibition of angiogenesis by
AECs [8,9], which is an effective way to treat cancer.
AECs are able to differentiate into the three germ layers (ectoderm, mesoderm and endoderm) and
express the cell surface markers associated with embryonic stem cells, such as SSEA-3, SSEA-4, TRA-1–
60, TRA-1–81 as well as transcriptional factors Oct-4 and Nanog [10,11].
While AECs express the non-polymorphic, non-classical human leukocyte antigen (HLA-G) on their
surfaces [12], they lack the polymorphic antigens HLA-A, HLA-B and HLA-DR [13]. Therefore, these cells
have been deemed non-immunogenic [14]. However, some studies have shown that the
immunogenicity of AECs increased after culture or differentiation [12,15,16I], potentially affecting the
transplant fate of these cells.
Since, the interaction of cells and the extracellular matrix (ECM) can affect many cell behaviours, such
as attachment, migration, proliferation and induction of immune response [17,18], the use of culture
condition near to in vivo, for example using three-dimensional matrices (scaffold), would help the cells
stay in their native status [19]. Scaffolds are made of common biocompatible and biodegradable
materials in form of porous matrices to help cells attach better. The pore size, porosity and

biodegradation rate are the most important factors in designing a suitable scaffold. The degradation
rate of scaffold should be proportional to the new tissue formation rate in order to remove the need
for removing the scaffold by surgery. Moreover, not only the physical and chemical properties of
scaffolds determine its success, but also the mechanical properties play a crucial role in scaffolds’
biocompatibility [20,21]. In this regard, numerous natural and synthetic polymers have been used to
date for scaffold fabrication and many investigations have been carried out to optimize their properties
for specific applications [22].
Gelatine is a biopolymer derived from collagen. It possesses desirable properties, such as low antigenic
property, lack of harmful by-products in enzymatic degradation, cost-effectiveness and high contents
of arginine-glycine-aspartic acid (RGD) motifs and functional groups in its structure, which mediate cell
attachment. The main concern for using gelatine in biomedical applications is its low strength and
stability in the body. Thus, it is usually composited with other materials [23,24,25].
Chitosan is a linear polysaccharide derived from deacetylation of chitin. It has an analogous structure
of glycosaminoglycans (GAGs) which are abundant in ECM. Due to its biocompatibility and antibacterial
properties, it has achieved a high scientific popularity in various biomedical applications [26,27].
It has been shown that fabricating composite porous scaffolds based on gelatine and chitosan,
enhances their biological and mechanical properties [28–30]. The aim of this study was to investigate
the effect of physicochemical properties of 2D and 3D scaffolds, based on gelatine and chitosan, on
HLAs expression in AECs.

Materials and methods
Preparation of chitosan–gelatine scaffolds

To prepare the 2D bed and 3D scaffolds, chitosan (LMW, Sigma, St. Louis, MO) and gelatine (type A,
Sigma, St. Louis, MO) were dissolved in 1% (w/v) acetic acid in distilled water at 37 °C with a ratio of
1:3. In order to evaluate the effect of freezing conditions on 3D matrices’ properties, 350 µl of
homogeneous suspension was poured into 24 well tissue culture plates and placed in −20 and −80 °C
freezers for 1, 2 and 4 h. The frozen samples were lyophilized (ZIRBUS, Bad Grund, Germany) for 12 h.
To form the 2D membrane, 24 well plates were completely covered by the chitosan–gelatine mixture
and dried at room temperature.

Scaffolds characterizations

In order to evaluate the effects of preparation conditions on scaffolds structure and to select the most
appropriate scaffold for cell seeding, different characteristics of 3D scaffolds were investigated as
described below.
Morphology analysis
The scaffolds’ morphology was evaluated by a scanning electron microscope (AIS2100, Seron
Technologies, Uiwang-si, Korea). The mean pore size of each scaffold was measured using ImageJ
software (National Institutes of Health, Bethesda, MD).

Porosity measurement
The liquid displacement method was used to measure the porosity of scaffolds [31]. Briefly, the
scaffolds were placed in a known volume of absolute ethanol (V1) for 5 min. The volume after scaffold
immersion and the remaining volume after removing the scaffolds were recorded as V2 and V3,
respectively. The porosity of scaffolds was calculated using the following equation:

Porosity % = �

Evaluation of scaffolds swelling behaviour

𝑉𝑉1 − 𝑉𝑉3
� × 100
𝑉𝑉2 − 𝑉𝑉3

To determine the swelling behaviour of scaffolds, the dried samples of scaffolds were weighed (Wd)
and then immersed in phosphate buffer saline (PBS) at 37 °C for 24 h. The samples were weighed again
after removing their surface water (Ww) and then centrifuged at 500 rpm for 3 min to record the final
weight (W′w). The swelling and water retaining capacity of scaffolds were measured using the following
equation [32]:

𝑊𝑊w − 𝑊𝑊d
� × 100
𝑊𝑊d
𝑊𝑊′w − 𝑊𝑊d
Water retaining % = �
� × 100
𝑊𝑊d
Swelling % = �

Contact angle measurement

OCA PLUS 15 instrument (Dataphysics, San Jose, CA) was used to evaluate the degree of hydrophilicity
of scaffolds. Three water droplets with a volume of 0.5 µl were put on each sample to measure the
water contact angle.

Evaluation of scaffolds biodegradability

Scaffolds were weighed (W0) and placed in 10 ml PBS at 37 °C to evaluate their biodegradability
properties for 21 d. Samples were weighed again (Wt) after being dried in 80 °C oven at distinct points
during this period. The biodegradability rate of scaffolds was determined by the following equation
[33]:

Biodegradation rate % = �𝑊𝑊0 −
Scaffold sterilization and neutralization

𝑊𝑊𝑡𝑡
� × 100
𝑊𝑊0

All samples were sterilized using ethylene oxide gas and vacuumed by covers. Before cell seeding,
sterile scaffolds were neutralized with absolute ethanol for 30 min and then rinsed with sterile PBS
several times before being soaked in Dulbecco’s modified eagle medium (DMEM) for 30 min [29].

Amniotic epithelial cells isolation and culture

All Methods and experimental procedures of this study were in accordance with the experimental
guidelines and regulations and approved by the research ethics committee of Shahid Beheshti
University of Medical Sciences. Human placentas were obtained from healthy mothers having elective
caesarean and transported to the laboratory under sterile conditions in cold PBS. The written consent
for the use of these tissues was obtained from the parents. The AM was mechanically dissected from
the chorion and washed several times with cold PBS to remove blood. To extract AECs, the AM was
divided into 3–4 pieces and transferred into tubes containing 30 ml 0.15% trypsin-EDTA (Sigma) and
incubated at 37 °C for 10 min. The first digestion was discarded to avoid debris and blood
contamination. The extracted cells from the second and third digestions (20 min each) were poured
over mesh (100 µm) and suspended in PBS containing 10% foetal bovine serum (FBS, Gibco, Carlsbad,
CA). AECs were counted and their viability was determined by trypan blue exclusion. DMEM/F12
(Gibco, Carlsbad, CA) containing 10% FBS to which 100 U/ml penicillin-streptomycin and 10 ng/ml
epithelial growth factor (EGF, Sigma, St. Louis, MO) was used as cell culture medium. The cells were
seeded on the 2D and 3D scaffolds, respectively, following by incubating (37 °C, 5% CO2) for 1 h to
achieve the initial cell attachment, and then the medium was added to each well to a final volume of
0.5 ml [34].

Cell attachment

Cell attachment to the scaffolds was evaluated by SEM and MTT (methylthiazol tetrazolium) assay. 3D
scaffolds were washed with PBS to remove suspended cells 24 h after cell seeding. Medium containing
10% MTT was added and incubated for 4 h at 37 °C. Then MTT was replaced with dimethyl sulfoxide
(DMSO) (30 min). The scaffolds without cells were considered as controls.

Purification of human macrophages

In this study, macrophages served as an HLA class I and HLA-DR expression control, purified by
Histopaque (Sigma-Aldrich, St. Louis, MO) gradient. To isolate monocyte/macrophage cells, peripheral
blood mononuclear cells (PBMCs) were cultured in tissue culture plate (TCP) with complete medium
(RPMI +10% FBS +1% penicillin/streptomycin, Gibco, Carlsbad, CA) for 4 h. Then, non-adherent cells
(i.e. lymphocytes) were removed and the attached cells (i.e. macrophages) were used as a positive
control for immunocytochemistry assays [35].

Immunofluorescence staining

HLAs expression in native and cultured AECs was analysed by immunocytochemistry. All assessments
were performed by multiple blinded observers. AECs were detached from the 2D and 3D matrices
using trypsin-EDTA after a week and fixed on glass slides in cold acetone. The cells were blocked for
30 min with 1% bovine serum albumin (BSA), then incubated with the following specific antibodies:
primary antibodies Pan-cytokeratin (1:100, Sigma-Aldrich, St. Louis, MO), MHC class I conjugated to
FITC (1:100, Sigma-Aldrich, St. Louis, MO), HLA- DR (1:50, ab20718, Abcam, Cambridge, UK), HLA-G
(1:100) (ab7758, Abcam, Cambridge, UK). Labelled antibodies with phycoerythrin (PE) (1:100, ab7002)
and fluorescein isothiocyanate (FITC) (1:100, Sigma-Aldrich, St. Louis, MO) were used as secondary
antibodies. Isotype immunoglobulin (Sigma-Aldrich, St. Louis, MO) was used as a negative control for
each antibody and HLA-G-positive human choriocarcinoma cell JEG-3 and macrophage cells were used
as positive controls. After the incubation period, the cells were rinsed with PBS and cell nuclei were

stained with DAPI for 1 min. Samples were analysed using a fluorescence microscope (Nikon, Tokyo,
Japan).

RT-PCR analysis

Total RNA was isolated (RNeasy Mini Kit; Qiagen, Hilden, Germany) from AECs immediately after
isolation and after 7 d of culture on the 2D membrane and 3D scaffolds according to the
manufacturer’s instructions. RNA concentration was measured with the Biophotometer (Eppendorf,
Hamburg, Germany) at 260 nm. Of 2 µg RNA was used as template for One-Step RT-PCR Kit (Qiagen,
Hilden, Germany) and reactions were carried out at 39 cycles of 50 °C (30 min), 95 °C (15 min), 94 °C
(45 s), 62–68 °C (45 s), 72 °C (1 min), followed with 72 °C (10 min). PCR products were visualized in 1.5%
agarose gels. β-Actin was used as internal control and macrophage cells (HLA class I & HLA-DR) as well
as JEG-3 cell line (HLA-G) were used as transcription controls. Primer sequences and annealing
temperatures are listed in Table 1.
Table 1. Primer sequences and annealing temperatures for the evaluated markers.
Primers and annealing temperatures
5′-TAT GTG GGC GAC GAG GCC CAG AGC-3′
5′-TGA AGC TGT AGC CGC GCT CGG TGA-3′(annealing temperature: 68 °C)
5′-GTC ATG GCG CCC CGA ACC CTC C-3′
5′-CGC GGC GGT CCA GGA GCG CAG G-3′(annealing temperature: 68 °C)
5′ AAG CGC CAG GCA CAG GCT GACC-3′
5′-AAG GAC AGC TAG GAC AAC CAG G-3′(annealing temperature: 62.2 °C)
5′-CAG CAT GGT GTG TCT GAA GCT CCC-3′
5´ -TGA GGA TGG ACT CGC CGCTGC AC-3′(annealing temperature: 65.7 °C)
5′ AGA CGC CAA GGA GG TGG TCA T-3′
5′-TCT CCA GGT ATC TGT GGA GCC AC-3′(annealing temperature: 65 °C)

Target
Forward
Reverse β-actin
Forward
Reverse HLA-AB
Forward
Reverse HLA-C
Forward
Reverse HLA-DR
Forward
Reverse HLA-G

Statistical analysis

All experiments were performed at least three times and data were assessed as the mean ± SD using
GraphPad Prism software version 7.01 (La Jolla, CA). Statistical significance was determined by oneway analysis of variance (ANOVA) followed by Tukey’s post-test. A p values less than .05 was
considered statistically significant.

Results
SEM observations

Figure 1 shows the microscopic images of 3D chitosan–gelatine scaffolds prepared in different prefreezing conditions and Figure 2(a) presents their mean pore size. It can be seen that increasing the
freezing time increases the pore size in all pre-freezing temperatures. On the other hand, pore size is
smaller when the scaffold is frozen in the lower temperature. It may be due to the increase in freezing
rate. The scaffold with freezing temperature and time of −20 °C and 1 h has a mean pore size of
approximately 80 µm which could be a suitable scaffold for cell culture.

Figure 1. SEM images of chitosan–gelatine scaffolds prepared at (a) − 20 °C for 1 h, (b) − 20 °C for 2 h, (c) − 20 °C for 4 h, (d)
− 80 °C for 1 h, (e) − 80 °C for 2 h and (f) − 80 °C for 4 h.

Figure 2. (a) The mean pore size of chitosan–gelatine scaffolds prepared at different pre-freezing temperatures and times.
The pore size increased by increasing the pre-freezing time. Also, preparation at lower temperature yields smaller pores
than higher temperature in the similar freezing time. (b) The results of porosity measurement of chitosan–gelatine scaffolds
prepared at different pre-freezing temperatures and times. The results indicated that decreasing the pre-freezing
temperature significantly decreases the porosity of scaffold in all preparation times. (c) Swelling characteristics and (d)
Water retaining of chitosan–gelatine scaffolds prepared at different pre-freezing temperatures and times. Increasing the
pre-freezing temperature increased both properties significantly. Furthermore, the swelling ratio and water retaining of
scaffolds are higher when frozen for shorter times (*p < .05, **p < .01 and ***p < .001).

Porosity of scaffolds

Figure 2(b) shows the porosity of scaffolds prepared in different pre-freezing conditions. It can be
perceived that increasing the freezing time from 1 to 4 h reduces the porosity of scaffolds,
independent of the freezing temperature. Although, increasing the time produces larger pores, they
have thick walls inhibiting the interconnection and porosity. Moreover, preparation in higher
temperature leads to an increased porosity in scaffolds because they have been formed in a lower
freezing rate and have larger pores with thin walls which makes interconnection between pores. The
maximum porosity of 80% belonged to chitosan–gelatine scaffold frozen in −20 °C for 1 h which makes
it a suitable scaffold for cell seeding.

Swelling behaviour of scaffolds

As displayed in Figure 2(c,d), the longer freezing time and lower freezing temperature both decrease
the swelling ratio and water retaining of scaffolds since the less porous scaffolds have been formed in
these conditions. Due to the importance of water absorption for a scaffold to provide cells with a
suitable environment, the chitosan–gelatine scaffold prepared at −20 °C for 1 h with 24.71% swelling
and 16.14% water retaining could be a great candidate to evaluate its impacts on immunological states
on AECs.

Scaffolds hydrophilicity

Water contact angle measurements showed that increasing the freezing time and decreasing the
freezing temperature both yield a higher contact angle meaning more hydrophobicity of the structure
(Figure 3(a)). Water contact angle for chitosan–gelatine (−20 °C and 1 h) was 23.8°, the most
hydrophilic scaffold among all samples.
Figure 3. (a) The results of contact angle measurement of chitosan–gelatine scaffolds prepared at different pre-freezing
temperatures and times. When prepared in a determined time, decreasing the temperature increased the contact angle
which indicates a more hydrophobic surface. (b) The degradation profiles of chitosan–gelatine scaffolds prepared at
different pre-freezing temperatures and times. (c) SEM image of amniotic epithelial cells attached to the chitosan–gelatine
scaffold (***p < .001).

Biodegradation of scaffolds

As shown in Figure 3(b), increasing the freezing time and decreasing the freezing temperature yield
higher rates of scaffold degradation. In these preparation conditions, the scaffolds have either smaller
partially interconnected pores or pores with thick walls so a larger area is exposed to the degrading
agent and the scaffold degrades faster.

Cell attachment

The SEM image of attached AECs to the 3D chitosan–gelatine scaffold prepared at −20 °C for 1 h is
depicted in Figure 3(c). The scaffold was able to provide a suitable bioenvironment to support cell
attachment.

HLA expression

Expression of HLA class I, HLA-DR, HLA-G molecules in AECs was evaluated by immunofluorescence
staining. The pan-cytokeratin specific antibody was used to detect AECs and confirm no contamination
with amnion mesenchymal cells during isolation process. Results showed that fresh AECs express HLAG molecules with high intensity and MHC class I molecules with very low intensity, whereas, these cells
were not reactive with the anti-HLA-DR antibody. After 7 d of culture on the 2D and 3D matrices, HLAG expression did not show significant alteration in AECs cultured on both matrices as compared to
fresh AECs, but HLA- DR expression was up-regulated after culture on the 2D and 3D matrices with the
same intensity. MHC class I was up-regulated in AECs cultured on 2D bed, whereas, there were no

significant differences between fresh AECs and those of embedded in the 3D scaffold (Table
2 and Figures 4, 5).
Figure 4. Immunofluorescence staining of fresh AECs (a) and control groups (b). (a) AECs staining with specific antibodies
conjugated with FITC (green) and phycoerythrin (red), (b) Representative image of negative and positive controls; from the
left: negative control in all immunocytochemical experiments in which the primary antibody was deleted; macrophage
(MQ) cells as positive control for HLA-DR; macrophage (MQ) cells as positive control for HLA class I; and choriocarcinoma
(JEG-3) cell line as positive control for HLA-G antibody, respectively. Inset shows nuclear staining by DAPI for the same
images. (Scale bar = 100 µm).

Figure 5. Up: fluorescence staining of AECs by specific antibodies after 7 d culture on 2D bed. Down: fluorescence staining
of AECs by specific antibodies after 7 d culture on 3D scaffolds. Inset shows nuclear staining by DAPI for the same images
(scale bar = 100 µm).

Table 2. The marker expression of fresh (0) and cultured AECs (for 7 d) on 2D and 3D scaffolds.

Marker
Culture 0 Culture (7 d) 2D Culture (7 d) 3D
Pan-cytokeratin ++++
++++
++++
MHC class I
+
++
+
HLA-DR
−
++
−
HLA-G
++++
+++
++++
++++: high intensity; +++: moderate to high intensity; ++: moderate intensity; +: low intensity; −: negative.

RT-PCR

One step RT-PCR was conducted to investigate HLAs expression in fresh and cultured AECs. Because of
gene overlapping between HLA-A and HLA-B, a common primer was designed for two genes. The
expression of HLA-AB, HLA-DR, HLA-G and at a lower intensity, HLA-C were detected in fresh AECs.
After 7 d culture, a significant decrease was observed in expression of HLA-AB, HLA-C and HLA-G. MHC
class I was expressed with lower intensity in AECs cultured on the 3D scaffold in comparison with the
cells cultured on the 2D membranes. There was not any observable band for HLA-DR expression after
culture under both 2D and 3D condition (Figure 6).

Figure 6. RT-PCR analysis of fresh AECs. (a) Two band for HLA-G is related to different isoforms of this molecule (soluble and
membrane-bond). Macrophage cells (MQ) were used as positive control for HLA-AB, HLA-C and HLA-DR expression. (b) JEG3 cell line as positive control for HLA-G expression.

Discussion

Structural differences between 2D cell culture and in vivo cellular niches led to efforts to develop 3D
culture models, which are more similar to the body’s microenvironment. 3D models affect many
cellular mechanisms such as adhesion, migration and differentiation properties. Several factors
contribute to cell fate cultured on 2D and 3D matrices, for example, different ligand distribution
(especially for integrins), can modify intracellular signalling pathways which affects cell surface
molecule expression, growth, differentiation and cell apoptosis [36,37].
In this study, we used chitosan–gelatine scaffolds as 3D matrices. Chitosan was mixed with gelatine to
take advantage of biocompatibility, bioabsorbability and non-immunogenic properties [38]. The 3D
scaffolds and 2D membranes were prepared and the scaffold pore size was determined for cell
seeding. The optimal results were achieved when the 3D scaffolds were pre-frozen at −20 °C for 1 h.
Based on these results, a mean pore size of 80 µm and 80% porosity are optimal to support the growth
of AECs. The results were consistent with the study of Kang et al. in which demonstrated that freezing
gelatine scaffolds in lower temperatures caused the formation of smaller pores because of increasing
freezing rate [39]. Moreover, Huang et al. reported the similar results about chitosan–gelatine
scaffolds in which the pores are larger at −20 than −80 °C [29]. One of the characteristics which can
affect the adhesion of cells to the scaffolds is hydrophilicity which was achieved by pre-freezing at
−20 °C for 1 h. Using the SEM images and MTT assay to identify cell attachment showed that the
chitosan–gelatine scaffolds provided an effective attachment condition for AEC culture.
There is a scientific consensus on low immunogenicity of AECs [2]; however, there are some
controversial reports in some studies on HLA expression by these cells. Therefore, we measured HLA
molecule expression in fresh AECs. From the results of immunocytochemistry assay, we found that
fresh AECs express membrane HLA-G with high intensity, MHC class I (HLA-AB and HLA-C) with very low
intensity and are negative for HLA-DR. mRNA expression for all of the mentioned markers in fresh AECs
was consistent with protein markers except for HLA-DR mRNA which was positive. These findings
suggest that mRNA expression by native AECs refer to the nature of these cells. AECs arise out of
epiblast [10], therefore, similar to three germ cell lineages, these cells tend to express MHC class I and
HLA-DR mRNA, but it is inhibited because of suppressive mechanisms in amniotic fluid such as
transforming growth factor beta-1 and beta-2 (TGF-β1 and TGF-β2), and soluble HLA-G [40,41].
Therefore, it is rational to accept that omission of inhibitory signals would be resulted in expression of

MHC class I and non-classical MHC on AECs after isolation and culture of these cells. Consistent with
this idea, culture of AECs on 2D scaffold resulted in upregulation of MHC class I and HLA-DR protein
markers on the AECs surface and downregulation of HLA-G protein. In comparison to 2D culture, 3D
scaffold did not increase protein expression of MHC class I and HLA-DR. Moreover, HLA-G protein
expression remained unchanged in 3D culture. These results confirm that 3D structure can regulate
expression of markers in gene and protein levels and there is a capability to affect the immunological
state of stem cells with modification of physical properties of the scaffold. This data was consistent
with the report of Hudson et al. in which showed that immunological profile of human stem cells could
be manipulated using the modification of scaffold compositions [42]. Due to immunoprotective
features of the encapsulation technique [43,44], it seems 3D encapsulation of AECs within chitosan–
gelatine hydrogel would be a proper strategy to circumvent immunological response of the cells which
needs to be evaluated in the future studies.

Conclusions

According to the results of this study, 3D chitosan–gelatine scaffolds can preserve the AECs in their
native immunological state. While culturing these cells on the 2D substrate resulted in higher levels of
MHC class I and HLA-DR expression, AECs cultured on the 3D scaffold showing the expression levels
similar to fresh cells. These results alongside the results of previous related studies suggest that
manipulation of the physical and chemical structure of scaffolds could affect the immunological
response of cells and enable us to overcome the rejection problems in stem cell therapy. Further
studies would be required for the design of biomaterials specifically engineered to optimize the
modification of MHC class receptor expressions in the culture process.
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